To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF862TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
198 supporting clones for gene ZNF862 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU164247 embryonal carcinoma, cell line, testis .a 1 to 832 1 to 838   tiling clone,   838/853
(98 %)
17 diff
(98.1 %id)
BM843562 lymph node, stomach .a 24 to 219 1 to 196       196/196
(100 %)
0 diff
(100 %id)
DA570731 whole embryo, mainly head .a 25 to 788 2 to 765   capped   764/764
(100 %)
7 diff
(99.1 %id)
CA396163 eye, RPE/choroid .a 33 to 555 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
BI818327 pooled brain, lung, testis .a 41 to 291 1 to 267       267/269
(99 %)
22 diff
(91.9 %id)
NM_001099220.1   .a 54 to 6949 1 to 6896 exact RefSeq, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 6896/6896
(100 %)
0 diff
(100 %id)
DA797323 brain .a 55 to 589 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
CN272196 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 92 to 524 1 to 433       433/433
(100 %)
0 diff
(100 %id)
BQ720795 sympathetic trunk .a 98 to 782 1 to 691       691/928
(74 %)
9 diff
(99.1 %id)
CN314776 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 510 to 1136 1 to 627   tiling clone,   627/627
(100 %)
2 diff
(99.7 %id)
DA049588   .a 831 to 1257 2 to 428   tiling clone, capped   427/427
(100 %)
0 diff
(100 %id)
DW414243 Liver .a 855 to 1113 17 to 275   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 259/317
(81 %)
4 diff
(98.8 %id)
DA724031   .a 1925 to 2493 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA332106 hippocampus .a 2255 to 2845 2 to 592   tiling clone, capped   591/592
(99 %)
3 diff
(99.5 %id)
DA196882 amygdala .a 2881 to 3223 2 to 344   capped   343/343
(100 %)
0 diff
(100 %id)
DA398804 thalamus .a 2881 to 3417 2 to 538   tiling clone, capped   537/537
(100 %)
1 diff
(99.9 %id)
DA329994 hippocampus .a 3129 to 3467 2 to 340   capped   339/339
(100 %)
0 diff
(100 %id)
AU130459   .a 3233 to 3910 2 to 678   tiling clone, capped   677/677
(100 %)
2 diff
(99.8 %id)
DA110197 cerebellum .a 3273 to 3825 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA124713 cerebellum .a 3310 to 3825 2 to 519   capped   518/518
(100 %)
3 diff
(99.5 %id)
DB135717 thymus .a 3532 to 4086 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA878446 Prostate .a 3582 to 4150 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB144353 thymus .a 3705 to 4183 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
DA733111   .a 3727 to 4265 2 to 540   tiling clone, capped   539/542
(99 %)
3 diff
(99.5 %id)
DA390690 thalamus .a 4016 to 4603 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB164525 thymus .a 4032 to 4581 2 to 551   capped   550/554
(99 %)
2 diff
(99.7 %id)
BF346114 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4053 to 4795 1 to 738   tiling clone,   738/899
(82 %)
17 diff
(98.2 %id)
BF932583 nervous_tumor .a 4085 to 4444 389 to 36     Submitted on the opposite strand 354/390
(90 %)
0 diff
(100 %id)
AW901022 nervous_normal .a 4176 to 4536 4 to 363       360/363
(99 %)
0 diff
(100 %id)
CU451359 epidermis .a 4285 to 4468 13 to 196       184/199
(92 %)
2 diff
(99.0 %id)
BY800408 eye .a 4326 to 4915 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
DA717041   .a 4348 to 4884 2 to 539   tiling clone, capped   538/538
(100 %)
2 diff
(99.7 %id)
DB036343 testis .a 4658 to 5231 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DB504625 hypothalamus .a 4668 to 5141 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
AA548495 low-grade prostatic neoplasia, Prostate .a 4685 to 4908 1 to 224       224/247
(90 %)
6 diff
(97.6 %id)
AA552735 low-grade prostatic neoplasia, Prostate .a 4706 to 4908 1 to 203       203/226
(89 %)
5 diff
(97.8 %id)
AW501827 lymph .a 4728 to 5064 1 to 335       335/335
(100 %)
5 diff
(98.6 %id)
TI_154156954   .a 4735 to 5234 104 to 601       498/498
(100 %)
14 diff
(97.2 %id)
DA150731 amygdala .a 4761 to 5333 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DA045695 bladder .a 4847 to 5354 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
BE729871 melanotic melanoma, skin .a 4854 to 5551 1 to 685   tiling clone,   685/964
(71 %)
19 diff
(98.1 %id)
AA348176 heart .a 4948 to 5252 1 to 304       304/304
(100 %)
4 diff
(98.7 %id)
DB357523 whole embryo, mainly head .a 6385 to 6949 575 to 1   tiling clone,   575/575
(100 %)
14 diff
(97.6 %id)
DB364889   .a 6500 to 6944 444 to 1   tiling clone,   444/444
(100 %)
6 diff
(98.7 %id)
DB367660   .a 6521 to 6949 430 to 1   tiling clone,   430/502
(85 %)
12 diff
(97.7 %id)
AI024111   .b 1 to 333 334 to 2 R39L tiling clone,   333/334
(99 %)
1 diff
(99.8 %id)
DB242520 stomach, tumor tissue .c-u 1 to 481 2 to 482   tiling clone, capped   481/481
(100 %)
0 diff
(100 %id)
DA380270 thalamus .c-u 11 to 543 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA829245 placenta .c-u 18 to 560 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DA840558 placenta .c-u 18 to 548 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
CF593573 Human Placenta, placenta .c-u 19 to 534 23 to 541       519/982
(52 %)
13 diff
(98.7 %id)
BX419251 brain, fetal brain .c-u 24 to 920 1 to 895 C5X R28X E59X E75X G82X ...     895/895
(100 %)
4 diff
(99.6 %id)
BC092506 Placenta, normal .c-u 25 to 1888 1 to 1859 exact tiling clone, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 1859/1859
(100 %)
3 diff
(99.9 %id)
BM761391 lymph node, stomach .c-u 25 to 360 1 to 340       340/340
(100 %)
4 diff
(98.9 %id)
BF980931 duodenal adenocarcinoma, cell line, small intestine .c-u 31 to 289 1 to 259       259/259
(100 %)
0 diff
(100 %id)
CT000616 T-Lymphocytes .c-u 40 to 442 1 to 403       403/407
(99 %)
1 diff
(99.8 %id)
CR997697 T-Lymphocytes .c-u 41 to 345 1 to 305       305/307
(99 %)
1 diff
(99.7 %id)
AK054924 cerebellum .c-u 50 to 1822 1 to 1773 exact available from FLJ,   1773/1773
(100 %)
4 diff
(99.8 %id)
BG701112 brain, hippocampus .c-u 50 to 835 1 to 789 R47H H70D L71F R72G R73V ... available from MGC,   789/789
(100 %)
28 diff
(96.5 %id)
DA059685 cerebellum .c-u 51 to 548 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DA568375 whole embryo, mainly head .c-u 51 to 715 2 to 667 H69X A77X L78P L79A R80K ... capped   666/672
(99 %)
8 diff
(98.9 %id)
BC045757 Brain, hippocampus .c-u 55 to 1815 1 to 1761 R47H Q88K available from MGC, AAA Possibly primed on the genome, locally A rich (37/39 A in genome downstream of last aligned base) 1761/1761
(100 %)
10 diff
(99.5 %id)
CR617664 Placenta Cot 25-normalized .c-u 58 to 1791 1 to 1734 exact     1734/1734
(100 %)
0 diff
(100 %id)
BX334720 Placenta Cot 25-normalized .c-u 58 to 829 1 to 772 R6X W89X T100X S104Y     772/772
(100 %)
3 diff
(99.7 %id)
BQ897697 dorsal root ganglia .c-u 59 to 853 25 to 823 Q88P     799/941
(84 %)
19 diff
(98.0 %id)
CR999266 T-Lymphocytes .c-u 66 to 519 1 to 454       454/455
(99 %)
1 diff
(99.8 %id)
CR980703 T-Lymphocytes .c-u 75 to 442 1 to 368       368/370
(99 %)
1 diff
(99.8 %id)
CR616081 Neuroblastoma Cot 50-normalized .c-u 77 to 1803 1 to 1727 exact     1727/1727
(100 %)
0 diff
(100 %id)
AL529337 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 77 to 868 1 to 791 G8X T22X W26G R27G R28E ...     791/791
(100 %)
2 diff
(99.8 %id)
BX366047 Neuroblastoma Cot 50-normalized .c-u 77 to 916 1 to 841 exact     841/844
(99 %)
7 diff
(99.2 %id)
AL528931 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 77 to 894 1 to 815 S2X Q3Y A4V C5X R6X ...     815/819
(99 %)
24 diff
(97.1 %id)
AL529889 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 77 to 1104 1 to 1022 E76X W89L fully sequenced,   1022/1022
(100 %)
5 diff
(99.6 %id)
BI911486 leukocyte .c-u 77 to 784 37 to 752 H69Q V83S W84L I85D G86R ...     716/752
(95 %)
0 diff
(100 %id)
TI_57232799   .c-u 77 to 784 37 to 752 H69Q V83S W84L I85D G86R ...     716/752
(95 %)
0 diff
(100 %id)
DA898228 skeletal muscle .c-u 82 to 566 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
BM544226 ovary (pool of 3) .c-u 98 to 906 21 to 839 exact     819/1117
(73 %)
35 diff
(96.9 %id)
CR978562 T-Lymphocytes .c-u 99 to 500 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
CR980235 T-Lymphocytes .c-u 155 to 624 1 to 470       470/471
(99 %)
1 diff
(99.8 %id)
CR997705 T-Lymphocytes .c-u 289 to 562 274 to 1     Submitted on the opposite strand 274/411
(66 %)
5 diff
(98.8 %id)
AA364015 pineal body .c-u 432 to 719 1 to 288       288/288
(100 %)
2 diff
(99.4 %id)
BF170444 blood .c-u 489 to 591 1 to 101       101/108
(93 %)
3 diff
(97.3 %id)
BX350063 Placenta Cot 25-normalized .c-u 498 to 1106 622 to 1       622/941
(66 %)
30 diff
(96.9 %id)
CB987710 Pooled-Glandular .c-u 550 to 1274 1 to 736       736/869
(84 %)
33 diff
(96.3 %id)
BP422161 small intestine .c-u 674 to 1191 1 to 519     Submitted on the opposite strand 519/519
(100 %)
1 diff
(99.9 %id)
AL563290 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 922 to 1771 863 to 14       850/863
(98 %)
0 diff
(100 %id)
AA167385   .c-u 947 to 1402 1 to 454   fully sequenced,   454/454
(100 %)
3 diff
(99.4 %id)
AL563420 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 952 to 1807 858 to 1       858/858
(100 %)
10 diff
(98.9 %id)
BX334719 Placenta Cot 25-normalized .c-u 973 to 1775 815 to 15       801/815
(98 %)
0 diff
(100 %id)
H39161 brain .c-u 1004 to 1383 1 to 381   fully sequenced,   381/381
(100 %)
1 diff
(99.8 %id)
BX118619 brain .c-u 1005 to 1688 1 to 687       687/687
(100 %)
6 diff
(99.2 %id)
AA077107 brain .c-u 1023 to 1311 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
G30711   .c-u 1023 to 1311 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
TI_149293107   .c-u 1070 to 1844 819 to 56       764/875
(87 %)
0 diff
(100 %id)
AL529888 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c-u 1074 to 1793 720 to 11   fully sequenced,   710/720
(98 %)
12 diff
(98.4 %id)
AW894210 nervous_normal .c-u 1125 to 1534 8 to 420       413/425
(97 %)
10 diff
(97.7 %id)
R11350 liver and spleen .c-u 1157 to 1492 1 to 342   fully sequenced,   342/342
(100 %)
17 diff
(95.1 %id)
AA328896   .c-u 1161 to 1493 1 to 333       333/333
(100 %)
0 diff
(100 %id)
AW955628   .c-u 1162 to 1701 1 to 540       540/627
(86 %)
6 diff
(99.1 %id)
CB162832 Liver .c-u 1177 to 1836 660 to 1     Submitted on the opposite strand 660/660
(100 %)
2 diff
(99.7 %id)
AA077855   .c-u 1197 to 1447 251 to 1       251/252
(99 %)
1 diff
(99.7 %id)
BU682460 lung .c-u 1208 to 1840 633 to 1       633/633
(100 %)
0 diff
(100 %id)
BF896712 marrow .c-u 1235 to 1459 238 to 15     Submitted on the opposite strand 224/238
(94 %)
0 diff
(100 %id)
AI829679 pooled .c-u 1242 to 1822 586 to 8       579/586
(98 %)
0 diff
(100 %id)
DB354878 whole embryo, mainly head .c-u 1263 to 1822 559 to 1       559/559
(100 %)
9 diff
(98.4 %id)
DB296891 cerebellum .c-u 1290 to 1822 535 to 1       535/535
(100 %)
4 diff
(99.3 %id)
AW207684   .c-u 1317 to 1822 533 to 28       506/533
(94 %)
0 diff
(100 %id)
AW467663 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .c-u 1343 to 1822 480 to 1       480/480
(100 %)
0 diff
(100 %id)
BQ016173 lung, Metastatic Chondrosarcoma .c-u 1348 to 1840 496 to 1       496/502
(98 %)
9 diff
(98.3 %id)
AA936481 carcinoid, lung .c-u 1351 to 1814 464 to 1       464/465
(99 %)
0 diff
(100 %id)
H38953 brain .c-u 1353 to 1808 471 to 1   fully sequenced,   471/471
(100 %)
24 diff
(95.0 %id)
AI738447 colon, colon tumor, RER+ .c-u 1359 to 1826 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AA167386   .c-u 1372 to 1818 453 to 1   fully sequenced,   453/453
(100 %)
7 diff
(98.5 %id)
BE646060 B-cell, chronic lymphotic leukemia .c-u 1391 to 1834 444 to 1       444/444
(100 %)
0 diff
(100 %id)
DB373983 placenta .c-u 1401 to 1822 422 to 1       422/424
(99 %)
2 diff
(99.6 %id)
AI807308 carcinoid, lung .c-u 1406 to 1814 409 to 1       409/409
(100 %)
0 diff
(100 %id)
BM689825 eye, Retina Foveal and Macular .c-u 1406 to 1822 1 to 417   fully sequenced, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AI680469 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c-u 1436 to 1839 404 to 1       404/404
(100 %)
0 diff
(100 %id)
R14850 liver and spleen .c-u 1454 to 1828 387 to 1   fully sequenced,   387/387
(100 %)
22 diff
(94.4 %id)
AA960966 pooled .c-u 1480 to 1822 344 to 1       344/344
(100 %)
2 diff
(99.5 %id)
AI002249 carcinoid, lung .c-u 1491 to 1814 327 to 1       327/327
(100 %)
19 diff
(94.2 %id)
AW805899 uterus .c-u 1499 to 1745 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
AI280645 ovary, tumor, 5 pooled (see description) .c-u 1504 to 1815 310 to 1       310/310
(100 %)
2 diff
(99.4 %id)
BF109010 pooled .c-u 1541 to 1831 291 to 1       291/291
(100 %)
2 diff
(99.4 %id)
BM661857 eye, Retina Foveal and Macular .c-u 1578 to 1791 214 to 1   fully sequenced, Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 214/214
(100 %)
0 diff
(100 %id)
FN091014 breast carcinoma .c-u 1584 to 1670 88 to 4     Submitted on the opposite strand 85/88
(96 %)
0 diff
(100 %id)
T82326   .c-u 1623 to 1815 209 to 17   AAA Possibly primed on the genome, locally A rich (37/39 A in genome downstream of last aligned base) 193/193
(100 %)
0 diff
(100 %id)
DB197128 trachea .d 1 to 584 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
BQ054043 blood, natural killer cells, cell line .d 696 to 1681 1 to 1002   tiling clone,   1002/1060
(94 %)
32 diff
(97.0 %id)
BM043239 carcinoma, cell line, Prostate .d 1120 to 1554 1 to 437       437/567
(77 %)
4 diff
(99.3 %id)
BM049154 carcinoma, cell line, Prostate .d 1120 to 1742 1 to 629       629/630
(99 %)
15 diff
(97.7 %id)
BM047348 carcinoma, cell line, Prostate .d 1120 to 2034 1 to 914   tiling clone,   914/932
(98 %)
42 diff
(95.5 %id)
BQ581946 insulinoma, Pancreas .d 1308 to 1831 8 to 532   tiling clone, Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 525/532
(98 %)
0 diff
(100 %id)
BG775543 carcinoma, cell line, Prostate .d 1962 to 2031 858 to 929   tiling clone,   910/929
(97 %)
33 diff
(96.5 %id)
BG775816 carcinoma, cell line, Prostate .d 2097 to 2959 885 to 1   tiling clone,   885/892
(99 %)
39 diff
(95.7 %id)
BQ581619 insulinoma, Pancreas .d 2413 to 3007 611 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 595/595
(100 %)
0 diff
(100 %id)
DB348153 trachea .d 2460 to 3007 548 to 1       548/548
(100 %)
0 diff
(100 %id)
AI795911 Kidney .d 2518 to 3011 496 to 3   tiling clone,   494/496
(99 %)
0 diff
(100 %id)
AI087221 senescent fibroblast .d 2589 to 3002 420 to 7       414/420
(98 %)
0 diff
(100 %id)
DA112068 cerebellum .e 1 to 461 2 to 469   capped   468/473
(98 %)
8 diff
(98.4 %id)
DA112077 cerebellum .e 1 to 548 2 to 550 N51K R52Q W53M A54G T55Y ... tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
DA618272   .e 1 to 584 2 to 589 S2A tiling clone, capped   588/588
(100 %)
5 diff
(99.2 %id)
DB239047 trachea .e 16 to 593 2 to 579 exact capped   578/578
(100 %)
1 diff
(99.9 %id)
DA532571 brain .e 24 to 523 2 to 501 exact capped   500/500
(100 %)
0 diff
(100 %id)
BG254483 adenocarcinoma, cell line, Prostate .e 368 to 1080 12 to 728   tiling clone,   717/1071
(66 %)
18 diff
(98.4 %id)
BE898162 melanotic melanoma, skin .e 448 to 1248 1 to 801   tiling clone,   801/911
(87 %)
26 diff
(97.2 %id)
AK128787 subthalamic nucleus .f-u 1 to 1768 2 to 1769 exact tiling clone, available from FLJ,   1769/1769
(100 %)
5 diff
(99.8 %id)
DA367607 subthalamic nucleus .f-u 1 to 527 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
BQ882881 dorsal root ganglia .f-u 41 to 776 20 to 761       742/818
(90 %)
28 diff
(96.6 %id)
TI_57234823   .f-u 138 to 873 30 to 762       733/765
(95 %)
20 diff
(97.4 %id)
BI909589 leukocyte .f-u 142 to 873 1 to 728       728/731
(99 %)
18 diff
(97.6 %id)
BF969233 adrenal cortex carcinoma, cell line, adrenal gland .f-u 162 to 939 1 to 770       770/944
(81 %)
27 diff
(97.2 %id)
BF967283 brain, hypothalamus .f-u 220 to 964 1 to 736   fully sequenced,   736/736
(100 %)
26 diff
(96.5 %id)
CD723657 eye, lacrimal gland .f-u 278 to 915 1 to 638   tiling clone,   638/638
(100 %)
0 diff
(100 %id)
CD513434 brain, Pituitary .f-u 393 to 1251 1 to 863       863/865
(99 %)
8 diff
(99.1 %id)
AA601904   .f-u 657 to 1070 1 to 412       412/412
(100 %)
9 diff
(97.9 %id)
TI_154130353   .f-u 839 to 1763 1024 to 99 A2X K3X K4R E5R E6K ... AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 926/1021
(90 %)
32 diff
(96.9 %id)
AW502760 lymph .f-u 860 to 1132 8 to 280     Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 273/280
(97 %)
0 diff
(100 %id)
TI_154158440   .f-u 860 to 1352 84 to 578 P34A P71H Q72K G73A S74P ... tiling clone,   495/535
(92 %)
20 diff
(96.3 %id)
AW948649 prostate_tumor .f-u 883 to 1410 1 to 528 exact     528/528
(100 %)
1 diff
(99.9 %id)
AW948717 prostate_tumor .f-u 891 to 1261 1 to 370       370/370
(100 %)
7 diff
(98.2 %id)
BF314120 brain, neuroblastoma .f-u 931 to 1711 1 to 760 R35G L36W A37P P38L L39C ...     760/871
(87 %)
33 diff
(96.3 %id)
BM688232 eye, human retina .f-u 942 to 1321 1 to 379   fully sequenced, Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 379/379
(100 %)
6 diff
(98.5 %id)
BF967826 brain, hypothalamus .f-u 943 to 1705 783 to 11 A2Y K3V K4R E6V D7R ... fully sequenced,   773/783
(98 %)
0 diff
(100 %id)
BF873461 lung_tumor .f-u 947 to 1478 9 to 539 exact     531/540
(98 %)
13 diff
(97.6 %id)
BF873466 lung_tumor .f-u 948 to 1466 13 to 531 exact     519/531
(97 %)
0 diff
(100 %id)
BF873464 lung_tumor .f-u 951 to 1471 13 to 532 exact     520/535
(97 %)
6 diff
(98.9 %id)
TI_149315214   .f-u 972 to 1766 874 to 89 A2G K3E K4M E5T E6A ... AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 786/963
(81 %)
30 diff
(96.9 %id)
H59158 liver and spleen .f-u 1056 to 1497 11 to 468       458/469
(97 %)
23 diff
(95.1 %id)
BX118218 liver and spleen .f-u 1058 to 1763 1 to 706   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 706/706
(100 %)
0 diff
(100 %id)
H63218 liver and spleen .f-u 1058 to 1525 1 to 477       477/479
(99 %)
18 diff
(96.3 %id)
H53249 liver and spleen .f-u 1059 to 1506 1 to 453       453/458
(98 %)
14 diff
(97.0 %id)
AV649629 corresponding non cancerous liver tissue .f-u 1247 to 1764 1 to 517     Submitted on the opposite strand 517/619
(83 %)
4 diff
(99.4 %id)
AV649715 corresponding non cancerous liver tissue .f-u 1247 to 1768 1 to 522   AAA Submitted on the opposite strand 522/522
(100 %)
2 diff
(99.7 %id)
AV650865 corresponding non cancerous liver tissue .f-u 1247 to 1763 1 to 517   AAA Submitted on the opposite strand 517/517
(100 %)
0 diff
(100 %id)
AV650877 corresponding non cancerous liver tissue .f-u 1247 to 1763 1 to 517   AAA Submitted on the opposite strand 517/517
(100 %)
0 diff
(100 %id)
AV650924 corresponding non cancerous liver tissue .f-u 1247 to 1763 1 to 517   AAA Submitted on the opposite strand 517/517
(100 %)
0 diff
(100 %id)
DB310772 subthalamic nucleus .f-u 1250 to 1768 520 to 1       520/520
(100 %)
3 diff
(99.5 %id)
AW516549 cervix, tumor .f-u 1255 to 1765 512 to 2       511/512
(99 %)
0 diff
(100 %id)
AI217935   .f-u 1273 to 1769 503 to 7       497/503
(98 %)
0 diff
(100 %id)
AI807503 pooled .f-u 1273 to 1769 499 to 3       497/499
(99 %)
0 diff
(100 %id)
AI870440 anaplastic oligodendroglioma, brain .f-u 1273 to 1763 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI992185 thymus, pooled .f-u 1273 to 1769 497 to 1   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
CN479285 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 1273 to 1766 509 to 16   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 494/494
(100 %)
0 diff
(100 %id)
DB575869 hypothalamus .f-u 1280 to 1766 1 to 487     Submitted on the opposite strand 487/487
(100 %)
1 diff
(99.8 %id)
AI478769 pooled .f-u 1288 to 1768 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BQ270712 insulinoma, Pancreas .f-u 1291 to 1768 8 to 485   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 478/485
(98 %)
0 diff
(100 %id)
CK825334 insulinoma, Pancreas .f-u 1291 to 1502 8 to 219       212/219
(96 %)
0 diff
(100 %id)
BU726965 eye, human retina .f-u 1291 to 1768 494 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 478/478
(100 %)
0 diff
(100 %id)
AV651153 corresponding non cancerous liver tissue .f-u 1301 to 1669 1 to 369     Submitted on the opposite strand 369/369
(100 %)
1 diff
(99.8 %id)
AV651162 corresponding non cancerous liver tissue .f-u 1301 to 1661 1 to 361     Submitted on the opposite strand 361/361
(100 %)
1 diff
(99.8 %id)
AI864650 pooled .f-u 1304 to 1769 468 to 3       466/468
(99 %)
0 diff
(100 %id)
BP395968 pancreatic islet .f-u 1320 to 1735 1 to 416     Submitted on the opposite strand 416/417
(99 %)
1 diff
(99.8 %id)
AI376697   .f-u 1325 to 1769 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AA854703 parathyroid gland, parathyroid tumor .f-u 1332 to 1769 445 to 8       438/445
(98 %)
0 diff
(100 %id)
BF941365 dorsal root ganglia .f-u 1346 to 1767 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AW576599 lymph .f-u 1384 to 1763 397 to 18   AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base) 380/380
(100 %)
2 diff
(99.5 %id)
AA948062 carcinoid, lung .f-u 1449 to 1763 315 to 1       315/315
(100 %)
2 diff
(99.4 %id)
AA426274   .f-u 1459 to 1763 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AI862979 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 1503 to 1769 275 to 9       267/275
(97 %)
0 diff
(100 %id)
AI203790 lung .f-u 1545 to 1765 222 to 2       221/222
(99 %)
0 diff
(100 %id)
AV724667 hypothalamus .f-u 1547 to 1769 1 to 223       223/235
(94 %)
1 diff
(99.6 %id)
AA910876 Kidney .f-u 1636 to 1769 137 to 4       134/137
(97 %)
0 diff
(100 %id)
AA886690 Kidney .f-u 1641 to 1764 124 to 1       124/124
(100 %)
0 diff
(100 %id)
DA810657 brain .g 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DB453979 testis .h-u 1 to 488 1 to 488 exact tiling clone,   488/488
(100 %)
0 diff
(100 %id)
AA078404 placenta Gene ZNF862, variant not shown              
AB011115 brain Gene ZNF862, variant not shown       available from KIAA, Suspected internal deletion, this clone was ignored    
BF374160 stomach_normal Gene ZNF862, variant not shown              
DB298684 cerebellum Gene ZNF862, variant not shown              
DA095728 cerebellum Gene ZNF862, variant not shown       capped      
CN292195 embryonic stem cells, DMSO-treated H9 cellline Gene ZNF862, variant not shown              
GD147220   Gene ZNF862, variant not shown              
DB519425 testis Gene ZNF862, variant not shown         Submitted on the opposite strand    
AW058077 thymus, pooled Gene ZNF862, variant not shown              
BC113087 PCR rescued clones Gene ZNF862, variant not shown         This clone was ignored    
BQ446489 Knee, Osteoarthritic Cartilage Gene ZNF862, variant not shown       AAA Possibly primed on the genome, locally A rich (32/32 A in genome downstream of last aligned base)    
DB277631 uterus Gene ZNF862, variant not shown       capped This clone was ignored    
DB291891 uterus Gene ZNF862, variant not shown       capped This clone was ignored    
DB353076 uterus Gene ZNF862, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f-u, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C